Loading...
HSChapter 30
U.S. exports of miscellaneous medicaments (not in dosage form, nesoi) (HS 300390) totaled $127.3M in July 2026.
Importers of Miscellaneous Medicaments (Not in Dosage Form, NESOI) paid $14K in duties in July 2026 — an effective duty rate of 10% on $141K in dutiable value, based on actual customs collections rather than the published tariff schedule.
Last updated: July 2026 dataPortugal and Singapore lead US supply under this residual pharmaceutical heading, which captures antiviral, antifungal, antiprotozoal, and other anti-infective bulk preparations — as well as a broad NESOI category — that do not fit more specific headings and are not yet in retail dosage form. The US schedule subdivides the heading into five 10-digit lines (3003900120 through 3003900190) by therapeutic class, enabling more granular trade monitoring of critical drug categories such as antivirals and antifungals that have drawn supply-chain scrutiny since the COVID-19 pandemic. Ireland and China are also significant sources, underscoring the geographic concentration risk in global API supply chains. FDA establishment registration and cGMP compliance are mandatory for all entries.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
250 shipments/mo
The granular subdivision allows US trade authorities to monitor import volumes of specific therapeutic classes independently — a priority that intensified after supply disruptions exposed concentration risks in critical drug categories. It also facilitates targeted enforcement actions or trade-remedy measures at the class level without affecting the entire heading.
A significant share of global API manufacturing for anti-infectives is concentrated in a small number of countries and facilities. Importers should assess single-source dependency, maintain visibility into sub-tier suppliers (including starting materials), and review FDA warning letters or import alerts for their foreign manufacturers, as an active import alert can halt an entire product line at the border.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Dutiable Share | Duty Collected |
|---|---|---|---|---|---|
| 3003900190 | Medicaments not Measured Doses or for Retail NESOI | $58.0M | 0.02% | 0.24% | $14K |
| 3003900120 | Antivirals, Not Measured Doses or for Retail | $6.0M | 0.00% | 0.00% | -- |
| 3003900180 | Anti-Infective Meds not Meas Doses or Retail NESOI | $1.2M | 0.00% | 0.00% | -- |
| 3003900140 | Antifungals, Not Measured Doses or for Retail | $555K | 0.00% | 0.00% | -- |
| 3003900160 | Antiprotozoals, Not Meas Doses or for Retail | $0 | -- | -- | -- |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
Supplier Network
Get discovered by U.S. importers searching for HS 300390 — Miscellaneous Medicaments (Not in Dosage Form, NESOI). Be the first supplier listed.
ImportsExports
Imports
$65.7MYoY · Pro
Exports
$127.3MYoY · Pro
12-mo low · imports
YoY · ProThrough July 2026. Source: U.S. Census Bureau.
Exports · July 2026
destination
Netherlands and Ireland together take 54% of it.
customs district
origin
entry
rate provision · imports
98.0% enters free of duty; the effective duty rate is 0.02%.